Παρακολούθηση
Vassiliki Magafa
Vassiliki Magafa
assistant professor of Pharmacy, University of Patras
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα upatras.gr
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
S Tourdot, M Oukka, JC Manuguerra, V Magafa, I Vergnon, N Riche, ...
Journal of immunology (Baltimore, Md.: 1950) 159 (5), 2391-2398, 1997
711997
Comparison of the solution structures of angiotensin I & II: Implication for structure‐function relationship
GA Spyroulias, P Nikolakopoulou, A Tzakos, IP Gerothanassis, V Magafa, ...
European journal of biochemistry 270 (10), 2163-2173, 2003
662003
Substance P C-terminal octapeptide analogues augment tumor necrosis factor-α release by human blood monocytes and macrophages
WZ Ho, G Stavropoulos, JP Lai, BF Hu, V Magafa, S Anagnostides, ...
Journal of neuroimmunology 82 (2), 126-132, 1998
541998
Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin
M Koutsioumpa, G Drosou, C Mikelis, K Theochari, D Vourtsis, P Katsoris, ...
Vascular cell 4, 1-13, 2012
492012
Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II
F Magnani, CG Pappas, T Crook, V Magafa, P Cordopatis, S Ishiguro, ...
ACS chemical biology 9 (7), 1420-1425, 2014
362014
Redox N-alkylation of tosyl protected amino acid and peptide esters
D Papaioannou, C Athanassopoulos, V Magafa, N Karamanos, ...
Acta Chemica Scandinavica 48 (4), 324-333, 1994
351994
Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC …
S Ishiguro, K Yoshimura, R Tsunedomi, M Oka, S Takao, M Inui, ...
Cancer biology & therapy 16 (2), 307-316, 2015
332015
Isolation and synthesis of a host-selective toxin produced by Alternaria alternata
M Liakopoulou-Kyriakides, AL Lagopodi, CC Thanassoulopoulos, ...
Phytochemistry 45 (1), 37-40, 1997
301997
Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production
TR Valero, E Sturchler, M Jafferjee, G Rengo, V Magafa, P Cordopatis, ...
Pharmacology Research & Perspectives 4 (2), e00226, 2016
262016
Preparation of polymer-bound trityl-hydrazines and their application in the solid phase synthesis of partially protected peptide hydrazides
G Stavropoulos, D Gatos, V Magafa, K Barlos
Letters in Peptide Science 2, 315-318, 1996
251996
Structural studies and cytotoxicity assays of “aggregation‐prone” IAPP8–16 and its non‐amyloidogenic variants suggest its important role in fibrillogenesis and …
NN Louros, PL Tsiolaki, AA Zompra, EV Pappa, V Magafa, G Pairas, ...
Peptide Science 104 (3), 196-205, 2015
222015
Synthesis, liposomal formulation and thermal effects on phospholipid bilayers of leuprolide
V Saroglou, S Hatziantoniou, M Smyrniotakis, I Kyrikou, ...
Journal of peptide science: an official publication of the European Peptide …, 2006
212006
Thyroxine-binding antibodies inhibit T cell recognition of a pathogenic thyroglobulin epitope
YD Dai, P Eliades, KA Carayanniotis, DJ McCormick, YM Kong, V Magafa, ...
The Journal of Immunology 174 (5), 3105-3110, 2005
192005
Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7
M Fragiadaki, V Magafa, L Borovicková, J Slaninová, P Cordopatis
European journal of medicinal chemistry 42 (6), 799-806, 2007
152007
GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on …
AA Zompra, V Magafa, FN Lamari, A Nikolopoulou, B Nock, T Maina, ...
The Journal of Peptide Research 66, 57-64, 2005
152005
Facile Preparation of the 1-Hydroxybenzotriazolyl Ester of/V-Tritylpyroglutamic Acid and its Application to the Synthesis of TRH,[D-His2] TRH and Analogues Incorporating eis …
G Karigiannis, N Karamanos, G Stavropoulos, A Napoli, G Sindona, ...
Acta Chemka Scandinavica 49, 103-114, 1995
151995
Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand
IC Moschonas, TF Kellici, T Mavromoustakos, P Stathopoulos, V Tsikaris, ...
Platelets 28 (8), 812-821, 2017
142017
Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β
NI Chantzi, AK Meligova, E Dhimolea, CC Petrou, DJ Mitsiou, V Magafa, ...
Steroids 76 (10-11), 974-985, 2011
132011
Interaction of Hg (II) with tetrapeptides containing cysteinyl and histidinyl residues
V Magafa, G Stavropoulos, P Tsiveriotis, N Hadjiliadis
Inorganica chimica acta 272 (1-2), 7-17, 1998
131998
Interaction of Cu (ii) and Ni (ii) with the 63–93 fragment of histone H2B
K Zavitsanos, AMPC Nunes, G Malandrinos, C Kállay, I Sóvágó, V Magafa, ...
Dalton Transactions, 6179-6187, 2008
122008
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20